TrialEuropean heart journal2013

A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.

Thomas J Povsic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.